JG
PCRX icon

Jain Global’s Pacira BioSciences PCRX Stock Holding History

Jain Global’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Buy
+12,641
New +$299K ﹤0.01% 1357
2025
Q1 		– Sell
-17,906
Closed -$337K – 1276
2024
Q4 		$337K Buy
+17,906
New +$314K 0.01% 534

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jain Global's PCRX Position: Q2 2026 in Review

Jain Global opened a new position in Pacira BioSciences (PCRX) in Q2 2026: 12,641 shares worth $321K. The stake represents ﹤0.01% of the portfolio and ranks #1357 among its holdings. This is a return to the name: Jain Global previously reported a position in PCRX as recently as Q4 2024.

Jain Global first reported a position in PCRX in Q4 2024 and has held it in 2 quarters since. The position peaked at $337K in Q4 2024. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Jain Global held 12,641 shares of Pacira BioSciences worth $321K as of Q2 2026.
  • Pacira BioSciences was a new Jain Global position in Q2 2026.
  • Pacira BioSciences made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1357 holding.
  • Jain Global first reported a position in Pacira BioSciences in Q4 2024 and has held it in 2 quarters since.
  • Jain Global's Pacira BioSciences position peaked at $337K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.